Brown adipose tissue, commonly called brown fat, differs fundamentally from white adipose tissue. White fat primarily stores excess energy in large lipid droplets, whereas brown fat is specialized for dissipating chemical energy as heat. Its cells contain abundant mitochondria and high levels of uncoupling protein 1, or UCP1, a protein embedded in the inner mitochondrial membrane. Under cold conditions, UCP1 allows mitochondria to release the energy of nutrient oxidation as heat rather than capture it entirely in the form of ATP. This process, known as non-shivering thermogenesis, helps maintain body temperature without the rapid muscle contractions associated with shivering.

The study places calcium at the center of this metabolic response. Calcium ions are widely known for their roles in muscle contraction, neurotransmitter release and gene regulation, but they also act as rapid intracellular signals that coordinate energy use. Orai1 is a highly selective calcium channel located in the plasma membrane. It is best known as part of the store-operated calcium entry system, in which depletion of calcium inside the endoplasmic reticulum activates sensor proteins called STIM1. STIM1 then communicates with Orai1, opening the channel and allowing extracellular calcium to flow into the cell. In brown adipocytes, this influx appears to connect external physiological signals with the internal machinery responsible for mobilizing fuel and activating heat-producing mitochondria.

The connection begins with lipolysis, the enzymatic process that releases fatty acids from triglycerides stored in lipid droplets. These liberated fatty acids serve two purposes in brown fat. They provide mitochondria with substrates for oxidation, and they directly support the activity of UCP1. Without adequate fatty-acid delivery, brown adipocytes may possess mitochondria and UCP1 but lack the fuel and regulatory inputs required for robust thermogenesis. By identifying Orai1 as a regulator of lipolysis, the research suggests that calcium entry is not merely a secondary response to metabolic activation. Instead, it may help determine whether brown-fat cells can efficiently unlock their stored energy when heat production is needed.

The second major link is mitochondrial activation. Mitochondria must rapidly adjust their activity when brown fat is exposed to cold or stimulated by signals associated with increased energy expenditure. Calcium can influence mitochondrial metabolism by coordinating the supply of metabolic intermediates and modifying the activity of enzymes involved in fuel oxidation. Carefully controlled calcium transfer can therefore accelerate energy production, while excessive or poorly regulated calcium may damage mitochondria and promote cellular stress. The findings described in the study support a model in which Orai1-dependent calcium entry helps brown adipocytes reach the level of mitochondrial activity required for thermogenesis while coordinating that activity with the release of fatty acids.

This mechanism may help explain how brown fat integrates several layers of physiological regulation. Cold exposure activates the sympathetic nervous system, which releases norepinephrine and stimulates receptors on brown adipocytes. Those signals increase cyclic AMP and activate protein kinase A, a pathway traditionally regarded as the dominant controller of lipolysis and UCP1-dependent heat production. The new work indicates that this established pathway may operate in concert with calcium signaling through Orai1. Rather than acting as isolated switches, sympathetic signals, lipid-droplet enzymes, calcium channels and mitochondria may form an interconnected circuit that allows brown fat to respond quickly and proportionately to changes in body temperature.

The implications extend beyond the biology of cold adaptation. Brown-fat activity has attracted intense interest because it consumes glucose and fatty acids and can raise whole-body energy expenditure. Adults retain smaller amounts of brown or brown-like thermogenic fat than infants, but measurable depots can remain active, particularly under cold exposure. Researchers have therefore explored whether stimulating thermogenesis could contribute to strategies for obesity, insulin resistance or metabolic disease. The Orai1 pathway may represent one possible molecular target, although translating a cellular mechanism into a safe treatment would require substantial additional research. Calcium channels participate in many organs, so manipulating Orai1 systemically could affect immune cells, muscle, the nervous system or other tissues.

The study also underscores why the regulation of thermogenesis cannot be reduced to a single “on” switch. Heat production depends on timing, intensity and cellular context. Brown adipocytes must release fuel, transport it into mitochondria, oxidize it and direct the resulting energy toward heat. Each stage is vulnerable to imbalance. Excessive lipolysis could produce harmful lipid intermediates, while uncontrolled calcium accumulation could impair mitochondrial function. Understanding how Orai1 is activated, how long calcium signals persist and how those signals are terminated will be essential for determining whether the pathway promotes healthy metabolic flexibility or contributes to cellular stress under pathological conditions.

For now, the research adds Orai1-mediated calcium entry to the molecular map of brown-fat thermogenesis and presents calcium signaling as a functional bridge between fat mobilization and mitochondrial heat production. The findings do not mean that activating Orai1 alone would automatically cause weight loss, nor do they establish a ready-made therapy for metabolic disease. They do, however, reveal a mechanism that may help explain how brown adipose tissue synchronizes fuel availability with energy dissipation. As scientists continue to investigate thermogenic fat, this calcium-controlled connection could become an important part of efforts to understand—and eventually influence—the body’s capacity to burn energy as heat.

Subject of Research: Orai1-mediated calcium entry, lipolysis, mitochondrial activation and brown adipose tissue thermogenesis

Article Title: Orai1-mediated Ca²⁺ entry regulates lipolysis and mitochondrial activation in brown adipose thermogenesis

Article References: Kim, S., Nguyen, P.A., Park, KS. et al. “Orai1-mediated Ca²⁺ entry regulates lipolysis and mitochondrial activation in brown adipose thermogenesis.” Experimental & Molecular Medicine (2026). https://doi.org/10.1038/s12276-026-01808-x

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01808-x; published 13 August 2026

Keywords: Orai1, calcium signaling, Ca²⁺ entry, brown adipose tissue, brown fat, thermogenesis, lipolysis, mitochondria, UCP1, metabolism

One of the key pathways controlling calcium influx into cells is known as store-operated calcium entry (SOCE). This mechanism hinges on the endoplasmic reticulum (ER), the cell’s main calcium reservoir. When the calcium concentration within the ER drops, the protein stromal interaction molecule 1 (STIM1) detects this depletion and directly interacts with ORAI channels located on the plasma membrane. ORAI1, in particular, forms the core pore of the calcium release-activated calcium (CRAC) channel, facilitating calcium entry from the extracellular space into the cytoplasm. This influx triggers a cascade of downstream signaling events essential for normal cellular functions.

Advancing the understanding of this pathway, researchers led by Yubin Zhou at the Center for Translational Cancer Research, Texas A&M Health Institute of Biosciences and Technology, have engineered novel molecular tools that precisely regulate calcium entry through CRAC channels. Working alongside co-collaborators Guolin Ma from MD Anderson and Qing Deng from Purdue University, Zhou’s team recently published their findings in Nature Communications. The study unveils sophisticated genetically encoded calcium channel inhibitory binders, coined CRABs, which selectively disrupt STIM1-ORAI interactions, consequently modulating calcium influx.

The importance of CRAC channel activity is particularly significant in immune cells, especially T lymphocytes, which rely on sustained calcium signaling to activate transcription factors like NFAT. This activation drives essential immune responses by promoting cytokine production and cell proliferation. Dysregulation of this pathway can lead either to a failure of immune response, due to insufficient calcium signaling, or to pathological conditions when calcium influx is excessive, resulting in chronic immune activation and related disease states.

Previous molecular investigations had identified the critical components of SOCE: ORAI1 forms the calcium-selective pore while STIM1 serves as the calcium-sensing sensor embedded in ER membranes. Upon calcium store depletion, STIM1 undergoes a conformational change and migrates to ER-plasma membrane junctions where it binds to ORAI1, resulting in channel opening. Despite this molecular framework being elucidated, effective regulation within a living system had remained a challenge.

The pivotal insight from Zhou’s lab was the innovative use of ORAI-derived peptide sequences as molecular decoys. These decoys competitively bind STIM1, effectively blocking the natural STIM1-ORAI interaction required for CRAC channel activation. This approach of competitive inhibition offers a more refined regulatory strategy compared to traditional channel blockers that indiscriminately block ion flow. The CRABs thus function as selective regulators rather than blunt channel inhibitors, allowing for nuanced control over calcium signaling.

To demonstrate the therapeutic potential of these engineered inhibitors, the research team utilized a zebrafish model of Stormorken syndrome, a rare genetic disorder caused by gain-of-function mutations in CRAC channels. Patients with Stormorken syndrome experience a combination of symptoms including thrombocytopenia (low platelet count), bleeding disorders, muscle weakness, and miosis. Excessive calcium influx in affected cells leads to cellular toxicity and impaired physiological functions. By administering CRABs, the researchers successfully restored the production of thrombocyte progenitors, thereby alleviating bleeding tendencies associated with the syndrome.

The implications of this research extend far beyond a rare genetic disorder. Calcium signaling pathways are intimately tied to immune cell behavior, especially in the context of immunotherapy. CAR-T cell therapy stands at the forefront of immuno-oncology, harnessing engineered T cells to target and eliminate cancer cells. However, the efficacy and safety of CAR-T treatments are often compromised by tonic signaling — a state of chronic overactivation — and T cell exhaustion, both linked to dysregulated calcium influx.

Targeting calcium entry with tunable, genetically encoded inhibitors such as CRABs could revolutionize immunotherapy by enabling precise control over T cell activity. Instead of completely shutting down calcium signaling, which could diminish CAR-T cell effectiveness, adjusting the calcium influx to optimal levels may enhance therapeutic durability and reduce adverse effects. This approach not only promises to extend the therapeutic window but also provides a mechanistic tool to modulate immune cell function with unprecedented specificity.

From a broader perspective, CRABs embody the future of precision medicine. By offering an adjustable molecular brake on calcium entry, researchers and clinicians gain a powerful method for dissecting the dynamic regulation of cell signaling in health and disease. Light- or chemical-inducible forms of these binders could provide temporal control, opening new avenues for targeted therapies that minimize systemic side effects.

Yubin Zhou envisions a transformative impact on the landscape of immune-related therapies. “Our goal is to develop molecular tools capable of fine-tuning cellular signaling pathways with high precision,” Zhou noted. “CRABs allow for scalable modulation of T cell activity, which can aid both in understanding pathological mechanisms and in designing safer, more effective immune cell-based treatments.”

In conclusion, the engineering of CRAC channel inhibitory binders marks a significant milestone in cellular biology and therapeutic development. By elucidating and harnessing the delicate balance of calcium signaling, this research bridges the gap between fundamental science and clinical application. The innovation demonstrated by Zhou’s team not only provides critical insights into calcium channel regulation but also lays the groundwork for novel approaches to treat immune dysregulation and improve the outcomes of cellular immunotherapies.

Subject of Research: Cells

Article Title: Engineering of genetically encoded programmable calcium channel inhibitory binders

News Publication Date: April 13, 2026

Web References: DOI: 10.1038/s41467-026-71769-2

Keywords: Calcium, CRAC channels, STIM1, ORAI1, store-operated calcium entry, immune cells, T cells, immunotherapy, competitive inhibition, Stormorken syndrome, CAR-T cell therapy, precision medicine